1. Home
  2. GKOS vs ALSN Comparison

GKOS vs ALSN Comparison

Compare GKOS & ALSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$153.58

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Logo Allison Transmission Holdings Inc.

ALSN

Allison Transmission Holdings Inc.

HOLD

Current Price

$122.34

Market Cap

9.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
ALSN
Founded
1998
1915
Country
United States
United States
Employees
N/A
4000
Industry
Medical/Dental Instruments
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
9.9B
IPO Year
2015
2011

Fundamental Metrics

Financial Performance
Metric
GKOS
ALSN
Price
$153.58
$122.34
Analyst Decision
Strong Buy
Hold
Analyst Count
12
7
Target Price
$126.92
$117.57
AVG Volume (30 Days)
692.4K
1.4M
Earning Date
04-29-2026
05-04-2026
Dividend Yield
N/A
0.84%
EPS Growth
N/A
N/A
EPS
N/A
1.33
Revenue
$507,442,000.00
$3,010,000,000.00
Revenue This Year
$23.32
$94.98
Revenue Next Year
$27.43
$5.30
P/E Ratio
N/A
$89.95
Revenue Growth
32.33
N/A
52 Week Low
$73.16
$76.01
52 Week High
$161.53
$137.62

Technical Indicators

Market Signals
Indicator
GKOS
ALSN
Relative Strength Index (RSI) 61.97 60.24
Support Level $96.44 $112.48
Resistance Level $161.53 $127.38
Average True Range (ATR) 5.46 3.11
MACD -0.85 0.81
Stochastic Oscillator 55.40 88.04

Price Performance

Historical Comparison
GKOS
ALSN

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About ALSN Allison Transmission Holdings Inc.

Allison Transmission is the largest manufacturer of fully automatic transmissions for medium- and heavy-duty commercial vehicles. Its automatic transmissions allow customers to achieve better fuel and operator efficiency than less expensive manual and automated manual transmissions. Allison serves several end markets, including on- and off-highway equipment and military vehicles. Its on-highway business commands approximately 60% global market share. The company's transmissions can be found in Class 4-8 trucks, buses, and a limited number of large passenger vehicles (heavy-duty pickup trucks and motorhomes). Allison also produces commercial hybrid propulsion systems and is developing fully electric powertrains.

Share on Social Networks: